Marie-Josée Martel, PhD
A dynamic HEOR, epidemiology, and market access expert, I am passionate about improving patient access to innovative treatments globally.
I bring over 20 years of global, regional and local/affiliate experience in HEOR and market access, from working for pharmaceutical companies, biotechs and healthcare consultancy in Canada, the USA and the United Kingdom.
I hold a PhD in Pharmaceutical Sciences, with a focus on pharmacoepidemiology, from the Université de Montréal and I am an invited speaker teaching study design at its Faculty of Pharmacy.
A recognized team leader and mentor, I have built, coached, and supported international multidisciplinary teams, actively developing strategic initiatives for both pipeline and marketed assets.
I have extensive experience translating scientific evidence into strategic value, having served as an employee and a consultant with a range of biotechs and large pharmaceutical companies:
As a Freelance Consultant
Developed and executed asset-specific HEOR strategic plans and value proposition for pipeline indications, provided HEOR support for clinical trial design and execution, endpoint strategy, psychometric validation, asset prioritization, launch preparation, and third-party collaborations.
As an Epidemiologist
Developed real-world / epidemiologic evidence for HTA and regulatory submissions, and US and European orphan designations.
As a Senior Consultant
In the US and UK, in a large healthcare consulting firm: provided strategic and global/HTA perspective to HEOR & market access projects for clients’ pipeline and marketed products, developed HTA documents for payers and decision-makers in North America, UK and Europe (eg: early scientific advice, submission dossiers, and presentations), facilitated healthcare stakeholder engagements through design, development and moderation of advisory boards, training initiatives and research collaborations.
As a Team lead
Grew the HEOR and market access presence of a large consulting firm in the UK and Switzerland, by recruiting, hiring and mentoring new team members, led business development and supported the establishment of operational infrastructure.
As a Global HEOR Associate Director
In the US headquarters of a large pharmaceutical company: hands-on leadership of global HEOR projects for the oncology pipeline, developed annual strategic and tactical plans, recommended inclusion and analysis of humanistic and economic outcome measures within clinical trials, assisted country teams on oncology pipeline-related needs.
As an Interim Market Access & HEOR Manager
In a large pharmaceutical company: led the Canadian Market Access head-office team responsible for product-specific market access, health economics, and pricing, oversaw the preparation of HTA submissions and research projects, helped prepare the governmental affairs and sales team with HEOR training and messaging.
As a Health Economics Manager
In the Canadian affiliate of a large pharmaceutical company: designed and led health economics and pharmacoepidemiology projects, developed Canadian (federal, provincial and private payers) reimbursement dossiers and scientific communications in English and French for key pharmaceutical products.